Hospital
El Camino Hospital
El Camino Hospital was paid $857K by Medicaid between Jan 2018 and Dec 2024, across 66 billing codes. Its largest line is 0450, Emergency room services — 35% of everything it billed.
33Billing provider infoEL CAMINO HOSPITAL
LOS GATOS, CA 95032
LOS GATOS, CA 95032
33aNPI1417199340assigned 03/24/2009
33bProvider typeGeneral Acute Care Hospital
28Total paid$857K
24GClaims58,113
24DCodes billed66
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#275 of 410
Median peer was paid$6.90M
This provider vs. median0.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,618 | $72K | |
| 2019 | 5,837 | $70K | |
| 2020 | 5,272 | $74K | |
| 2021 | 7,585 | $101K | |
| 2022 | 9,029 | $180K | |
| 2023 | 11,943 | $178K | |
| 2024incomplete | 11,829 | $181K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0450 | Emergency room services | 35% | 13,370 | 12,130 | $297K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 12% | 673 | 663 | $102K |
| 99199 | Unlisted special service, procedure or report | 11% | 1,865 | 1,645 | $93K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 7.0% | 717 | 709 | $60K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 4.5% | 3,603 | 3,444 | $38K |
| 80053 | Comprehensive metabolic panel | 3.2% | 5,552 | 5,138 | $27K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.1% | 788 | 765 | $27K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.0% | 289 | 286 | $26K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.7% | 817 | 775 | $23K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.4% | 6,185 | 5,648 | $21K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 2.1% | 128 | 128 | $18K |
| 71045 | Radiologic examination, chest; single view | 1.7% | 2,120 | 2,055 | $15K |
54 more codes
| 96375 | Therapeutic injection; each additional sequential IV push | 1.4% | 579 | $12K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 536 | $8K |
| 84484 | <1% | 1,863 | $7K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 164 | $6K |
| 83690 | <1% | 1,792 | $6K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 433 | $6K |
| 81025 | <1% | 1,866 | $5K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,451 | $5K |
| 81001 | <1% | 2,790 | $4K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 223 | $4K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,089 | $4K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,281 | $4K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 129 | $4K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 50 | $3K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,183 | $3K |
| 99283 | Emergency room visit (moderate) | <1% | 148 | $3K |
| 87631 | <1% | 92 | $3K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 234 | $2K |
| 81003 | <1% | 1,964 | $2K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 363 | $2K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 224 | $2K |
| 87581 | <1% | 128 | $2K | |
| 87486 | <1% | 116 | $2K | |
| 83605 | <1% | 348 | $2K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 181 | $1K |
| 99284 | Emergency room visit (serious) | <1% | 223 | $1K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,040 | $1K |
| 83880 | <1% | 61 | $855.39 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 41 | $764.75 |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 19 | $745.88 |
| 83735 | <1% | 209 | $625.48 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 121 | $436.45 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 98 | $386.56 |
| 87040 | <1% | 76 | $379.70 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 110 | $367.27 |
| 82553 | <1% | 48 | $355.98 | |
| J3490 | Unclassified drugs | <1% | 106 | $314.96 |
| 85610 | <1% | 169 | $251.52 | |
| 82550 | <1% | 60 | $209.20 | |
| 85379 | <1% | 39 | $116.04 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 24 | $114.68 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 12 | $108.75 |
| 85730 | <1% | 36 | $96.31 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 42 | $77.16 |
| 87081 | <1% | 12 | $51.28 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 14 | $44.36 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 13 | $42.08 |
| 36415 | Collection of venous blood by venipuncture | <1% | 80 | $29.24 |
| 0270 | <1% | 34 | $19.99 | |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | <1% | 15 | $12.34 |
| 87186 | <1% | 13 | $8.69 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 29 | $6.95 |
| A9270 | Non-covered item or service | 0% | 23 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWOO, MING-RONG (DIRECTOR REV & REIMB)
| Provider | Location | Paid |
|---|---|---|
| El Camino Hospital | Mountain View, CA | $6.41M |
| El Camino Hospital | Los Gatos, CA | $30K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.